Biotangents has secured £2.2m to support the development of its disease detection technology.
The new funding was made up of £1.6m from the UK Government’s Innovate UK loans programme and a further £600,000 from a round led by investment syndicate Kelvin Capital, with Scottish Enterprise also participating.
The Penicuik-based start-up also secured £1.2m in August 2021 in a round also led by Kelvin Capital, following an initial £1.5m worth of funding in May 2019.